Esther van den Boom - 15 Sep 2022 Form 4 Insider Report for Tyra Biosciences, Inc. (TYRA)

Role
Chief Financial Officer
Signature
/s/ Ali D. Fawaz, Attorney-in-Fact
Issuer symbol
TYRA
Transactions as of
15 Sep 2022
Net transactions value
+$11,120
Form type
4
Filing time
19 Sep 2022, 18:17:23 UTC
Previous filing
08 Sep 2022
Next filing
15 Aug 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TYRA Common Stock Award $11,120 +1,452 +1.2% $7.66 121,897 15 Sep 2022 Direct F1
holding TYRA Common Stock 118,645 15 Sep 2022 See footnote F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were acquired under the Issuer's 2021 Employee Stock Purchase Plan.
F2 Represents shares held by van den Boom Ventures LLC, of which the spouse of the Reporting Person is the managing member.